glp-1 and cancer risk Glucagon-like peptide 1 receptor agonists risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research GLP-1 Side Effects and Cancer

An orally active catalytic metalloporphyrin protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in vivo

The metabolome-wide signature of major depressive disorder

Thomas L, Mago P (2024) Unearthing the therapeutic benefits of culinary-medicinal mushrooms for humans: emerging sustainable bioresources of 21st century

Below, I have pulled together the best apps for GLP-1 users across 6 categories, from all-in-one companions to mindset tools, based on what they actually do and who they are best suited for

Eli Llly: Orfoglipron/LY3502970/ Formerly Chugai OWL833 Orfoglipron is an oral GLP1R agonist , taken daily due to its half life of 25-68 hours [28]